Company initiatives

  • , ,

    Novozymes buys 10% stake in Beta Renewables

    .

    Novozymes today announced its 10% acquisition stake worth $115m in Beta Renewables — a cellulosic biofuel joint venture between Chemtex (a division of Italian plastic producer Gruppo Mossi & Ghisolfi) and investment firm TPG. With this deal, Danish enzymes producer…

  • ,

    Zeachem completes cellulosic ethanol biorefinery

    .

    I am currently working on my weekly news roundup but in the meantime before Hurricane Sandy cuts off my electricity, I’ll post (separately) these news today that came from Zeachem and Novozymes. Let’s start with Zeachem, which announced today that…

  • ,

    Toyota Tsusho’s Bio-PET rolls out

    .

    It’s 2am and I’ll make this a quickie post before my eyes pop out of my head. Illinois, US-based Clear Lam Packaging announced yesterday that it has signed a deal with Toyota Tshusho for the use of its Bio-PET (polyethylene…

  • ,

    BP cancels US cellulosic ethanol plans

    .

    UK-based fuel giant BP seems to have caved-in to biofuel market pressures (and investor pressures) as it announced today that it will end its pursuit of commercial-scale cellulosic ethanol production in the US. BP said it is cancelling its plans…

  • , ,

    More delays for METEX’ bio-PDO

    .

    France-based METabolic EXplorer (METEX) is joining the ranks of other public industrial biotechnology firms (such as Amyris, Codexis, Gevo…) who are not too happy with the way their stocks are falling this year. Difficulty in financing and planned capacity delays…

  • , ,

    Zeachem looks at bio-propanol

    .

    Look at what I found! I have always been asking Zeachem what specific C3 chemicals they are looking into and now I have my (sort-of) answers from this slide presentation that Zeachem’s chief commercial officer Bob Walsh recently presented at…

  • Green Biologics’ biobutanol now available

    .

    I am still working on the weekly news roundup but in the meantime, the blog recently had a very interesting conversation with Green Biologics‘ vice president of business development, Tim Staub, on the company’s commercialization of its bio-based n-butanol. It…


You cannot copy content of this page